Overview

Gender

female

Dr. Critchley-Thorne is responsible for the development of novel cancer in vitro diagnostics based on Cernostics' proprietary Tissue Systems Pathology approach.

She is a cancer immunologist with expertise in molecular and functional profiling of patient samples and was previously a Senior Scientist at Cellumen, Inc. in the Patient Sample Profiling Program, responsible for the collaborative project on breast cancer diagnostics with the Mayo Clinic.

Dr. Critchley-Thorne completed post-doctoral training at Stanford University in the Department of Medicine, Division of Hematology where her research focused on functional profiling using multiplexed fluorescence immune biomarker analysis and also gene expression profiling of the immune system in cancer patient samples to identify mechanisms of tumor-induced immune dysfunction.

She earned her PhD in Oncology from Imperial College, London, UK where her thesis was on recombinant E. coli as vectors for cancer prodrug therapy and immunotherapy.